Chapter Ⅰ Summaries Related to Biopharmaceutical Industry
　　1.1 Brief introduction of biopharmaceutical manufacturing concept
　　1.2 Brief summary of biopharmaceutical industry
　　1.3 Main products introduction of biopharmaceutical
　　1.4 Different sources of biopharmaceutical
Chapter Ⅱ Development Analysis of International Biopharmaceutical
　　2.1 General overview of international biopharmaceutical
　　2.2 USA.
　　2.3 Europe
　　2.4 Singapore
　　2.5 Other countries
Chapter Ⅲ Development of Biopharmaceutical Industry in China
　　3.1 Development Environment of biopharmaceutical in China
　　3.2 Development summary of biopharmaceutical industry in China
　　3.3 Development of biopharmaceutical industry in China 2010
　　3.4 Analysis of biopharmaceutical market in China 2011
　　3.5 Development of biopharmaceutical industry in China 2011
　　3.6 Analysis of biopharmaceutical industry cluster development in China
　　3.7 Development problems of biopharmaceutical in China
　　3.8 Development strategies of biopharmaceutical industry in China
Chapter Ⅳ Economic Operation Data Analysis of Biopharmaceutical in China
　　4.1 Overall data analysis of biopharmaceutical enterprises in China 2010-2012 Jun.
　　4.2 Data analysis of different ownership enterprises of biopharmaceutical industry in China 2011-2012 Jun.
　　4.3 Data analysis of different scales enterprises of biopharmaceutical industry in China 2011-2012 Jun.
Chapter Ⅴ Blood products
　　5.1 Analysis of blood products industry in China
　　5.2 Problems existing in blood products industry in China
　　5.3 Development strategies of blood products industry in China
　　5.4 Prospect and investment risks analysis of blood products industry in China
Chapter Ⅵ Vaccine
　　6.1 Development overview of global vaccine market
　　6.2 Development of vaccine industry in China
　　6.3 Overview of vaccine category management in China
　　6.4 AIDS vaccine
　　6.5 Flu vaccine
　　6.6 Hepatitis B vaccine
　　6.7 Cancer vaccine
Chapter Ⅶ Genetic Engineering Drugs
　　7.1 Development analysis of international genetic engineering drugs
　　7.2 Development of genetic engineering drugs in China
　　7.3 Analysis of genetic engineering drugs industrialization in China
　　7.4 Development strategies and trend of genetic engineering drugs in China
Chapter Ⅷ Antibody Engineering Drugs
　　8.1 Development analysis of antibody engineering drugs
　　8.2 Development of monoclonal antibody drugs
　　8.3 Development of antibody engineering drugs technology
Chapter Ⅸ Diagnostic Reagents
　　9.1 Overview related to diagnostic reagents
　　9.2 Development of diagnostic reagents market in China
　　9.3 Development trend of diagnostic reagents in China
Chapter Ⅹ Development of Biopharmaceutical in Main Areas of China
　　10.1 Shandong Province
　　10.2 Zhejiang Province
　　10.3 Jiangsu Province
　　10.4 Guangdong Province
　　10.5 Hubei Province
　　10.6 City of Shanghai
Chapter Ⅺ Foreign Key Listed Enterprises
　　11.1 AMGEN
　　11.2 GENENTECH
　　11.3 BIOGEN IDEC
　　11.4 GENZYME
Chapter Ⅻ Domestic Key Listed Enterprises
　　12.1 Sino Biopharmaceutical Co., Ltd.
　　12.2 Unisplendour Guhan Group Co., Ltd.
　　12.3 Beijing Tiantan Biological Products Co., Ltd.
　　12.4 Shenzhen Neptunus Bioengineering Co., Ltd.
　　12.5 Ginwa Enterprise (Group) Co., Ltd.
　　12.6 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
　　12.7 Hualan Biological Engineering Inc.
　　12.8 Shanghai Kehua Bio-engineering Co., Ltd.
　　12.9 Da An Gene Co.,Ltd. Of SUN YAT-SEN University
　　12.10 Shenzhen CAU Technology Co.,Ltd.
Chapter ⅩⅢ Analysis of Competition Situation of Biopharmaceutical in China
　　13.1 Competition overview of medicine industry in China
　　13.2 Analysis of competition features of biopharmaceutical in China
　　13.3 Analysis of competition structure of biopharmaceutical in China
　　13.4 Suggestions for improving competitiveness of biopharmaceutical in China
Chapter ⅩⅣ Investment Analysis
　　14.1 Investment opportunities
　　14.2 Investment analysis of biopharmaceutical in China under the financial crisis
　　14.3 Financing analysis of biopharmaceutical enterprises in China
　　14.4 Evaluation analysis of venture capital projects of biomedical
　　14.5 Investment risk analysis of biopharmaceutical industry in China
　　14.6 Investment suggestions
Chapter ⅩⅤ Prospect and Trend of Biopharmaceutical Industry in China
　　15.1 Prospect and trend of international biopharmaceutical industry
　　15.2 Prospect and trend of biopharmaceutical industry in China